Michael J. Farrell Resmed Inc (RSMDF) insider trading activity

Michael J. Farrell is Chief Executive Officer of RESMED INC. Currently has a direct ownership of 455,503 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on May 07, 2024, when has been sold 14,683 shares (ResMed Common Stock) at a price of $84.98 per share, resulting in proceeds of $1,247,761. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 456K

0.01% 3M change

3.34% 12M change

Total Value Held $0

Michael J. Farrell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 07 2024	BUY Exercise of conversion of derivative security	$1,247,761 $84.98 p/Share	14,683 Added 3.12%	455,435 ResMed Common Stock
Nov 20 2023	SELL Payment of exercise price or tax liability	$350,306 $148.94 p/Share	2,352 Reduced 0.53%	438,633 ResMed Common Stock
Nov 15 2023	SELL Open market or private sale	$863,283 $152.04 p/Share	5,678 Reduced 1.27%	440,986 ResMed Common Stock
Nov 15 2023	BUY Exercise of conversion of derivative security	$327,961 $57.76 p/Share	5,678 Added 1.26%	446,664 ResMed Common Stock
Nov 13 2023	SELL Payment of exercise price or tax liability	$1,213,420 $143.6 p/Share	8,450 Reduced 1.88%	440,986 ResMed Common Stock
Oct 16 2023	SELL Open market or private sale	$798,472 $140.7 p/Share	5,675 Reduced 1.25%	449,360 ResMed Common Stock
Oct 16 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.23%	455,035 ResMed Common Stock
Sep 15 2023	SELL Open market or private sale	$830,536 $146.35 p/Share	5,675 Reduced 1.25%	449,360 ResMed Common Stock
Sep 15 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.23%	455,035 ResMed Common Stock
Aug 17 2023	BUY Grant, award, or other acquisition	-	12,430 Added 2.69%	449,360 ResMed Common Stock
Aug 15 2023	SELL Open market or private sale	$1,039,659 $183.2 p/Share	5,675 Reduced 1.28%	436,930 ResMed Common Stock
Aug 15 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.27%	442,605 ResMed Common Stock
Jul 17 2023	SELL Open market or private sale	$1,255,707 $221.27 p/Share	5,675 Reduced 1.28%	436,930 ResMed Common Stock
Jul 17 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.27%	442,605 ResMed Common Stock
Jun 15 2023	SELL Open market or private sale	$1,233,688 $217.39 p/Share	5,675 Reduced 1.28%	436,930 ResMed Common Stock
Jun 15 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.27%	442,605 ResMed Common Stock
May 15 2023	SELL Open market or private sale	$1,317,167 $232.1 p/Share	5,675 Reduced 1.28%	436,930 ResMed Common Stock
May 15 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.27%	442,605 ResMed Common Stock
Apr 17 2023	SELL Open market or private sale	$1,272,505 $224.23 p/Share	5,675 Reduced 1.28%	436,900 ResMed Common Stock
Apr 17 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.27%	442,575 ResMed Common Stock
Mar 15 2023	SELL Open market or private sale	$1,174,441 $206.95 p/Share	5,675 Reduced 1.28%	436,900 ResMed Common Stock
Mar 15 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.27%	442,575 ResMed Common Stock
Feb 15 2023	SELL Open market or private sale	$1,219,160 $214.83 p/Share	5,675 Reduced 1.28%	436,900 ResMed Common Stock
Feb 15 2023	BUY Exercise of conversion of derivative security	$327,788 $57.76 p/Share	5,675 Added 1.27%	442,575 ResMed Common Stock
Jan 17 2023	SELL Open market or private sale	$1,273,243 $224.36 p/Share	5,675 Reduced 1.28%	436,900 ResMed Common Stock

Also insider at

ZBH

ZIMMER BIOMET HOLDINGS, INC. Healthcare

Director

MJF